Pfizer Biontech Vaccine Uk
- All
- News
- Videos
-
UK Schoolchildren Aged 12-15 Years To Be Offered Covid Vaccine First Dose
Schoolchildren aged between 12 and 15 years will be offered a first dose of the Pfizer/BioNTech COVID-19 vaccine starting next week, the UK government has announced after the country's Chief Medical Officers gave their go-ahead for the jabs for young
-
COVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: Report
A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday.
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
-
Pfizer Vaccine For 12 To 15-Year-Olds Approved By UK Regulator
Britain's medicines regulator said Friday the Pfizer/BioNTech vaccine is safe for adolescents aged 12 to 15 after a "rigorous review", following similar assessments in the European Union and United States.
-
Helping India With British Science: UK As It Buys 60 Million More Covid Vaccines
An extra 60 million doses of the Pfizer/BioNTech vaccine have been secured to help support a booster Covid-19 vaccination programme beginning from the autumn months later in the year, the UK government said on Wednesday.
-
Even Single Vaccine Dose Cuts COVID-19 Infection Rate, New UK Study Finds
A single dose of either the Oxford/AstraZeneca or Pfizer/BioNTech vaccines, currently being administered in the UK, cut the rate of coronavirus infections by around 65 per cent, according to a new UK study on Friday.
-
Pfizer Covid Vaccine Reduces Transmission After One Dose: UK Study
A single dose of Pfizer and BioNtech's COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK study found on Friday.
-
Pfizer Vaccine Can Neutralise UK, South Africa Virus Variants: Study
The COVID-19 vaccine co-developed by the American pharmaceutical giant Pfizer and the German biotechnology company BioNTech can neutralise variants of the novel coronavirus that were first reported in the UK and South Africa, a new study suggests.
-
Pfizer-BioNTech Say Their Covid Vaccine Works Against UK, South Africa Variants
The vaccine made by Pfizer and BioNTech appears to retain its effectiveness against coronavirus mutations in worrying new variants that have emerged recently in Britain and South Africa, the firms said Thursday.
-
Pfizer Vaccine Likely To Protect Against UK Covid Variant: Study
The COVID-19 vaccine developed by Pfizer and BioNTech is likely to protect against a more infectious variant of the virus, which was discovered in Britain and has spread around the world, according to results of further lab tests released on Wednesday.
-
UK Schoolchildren Aged 12-15 Years To Be Offered Covid Vaccine First Dose
Schoolchildren aged between 12 and 15 years will be offered a first dose of the Pfizer/BioNTech COVID-19 vaccine starting next week, the UK government has announced after the country's Chief Medical Officers gave their go-ahead for the jabs for young
-
COVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: Report
A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday.
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
-
Pfizer Vaccine For 12 To 15-Year-Olds Approved By UK Regulator
Britain's medicines regulator said Friday the Pfizer/BioNTech vaccine is safe for adolescents aged 12 to 15 after a "rigorous review", following similar assessments in the European Union and United States.
-
Helping India With British Science: UK As It Buys 60 Million More Covid Vaccines
An extra 60 million doses of the Pfizer/BioNTech vaccine have been secured to help support a booster Covid-19 vaccination programme beginning from the autumn months later in the year, the UK government said on Wednesday.
-
Even Single Vaccine Dose Cuts COVID-19 Infection Rate, New UK Study Finds
A single dose of either the Oxford/AstraZeneca or Pfizer/BioNTech vaccines, currently being administered in the UK, cut the rate of coronavirus infections by around 65 per cent, according to a new UK study on Friday.
-
Pfizer Covid Vaccine Reduces Transmission After One Dose: UK Study
A single dose of Pfizer and BioNtech's COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK study found on Friday.
-
Pfizer Vaccine Can Neutralise UK, South Africa Virus Variants: Study
The COVID-19 vaccine co-developed by the American pharmaceutical giant Pfizer and the German biotechnology company BioNTech can neutralise variants of the novel coronavirus that were first reported in the UK and South Africa, a new study suggests.
-
Pfizer-BioNTech Say Their Covid Vaccine Works Against UK, South Africa Variants
The vaccine made by Pfizer and BioNTech appears to retain its effectiveness against coronavirus mutations in worrying new variants that have emerged recently in Britain and South Africa, the firms said Thursday.
-
Pfizer Vaccine Likely To Protect Against UK Covid Variant: Study
The COVID-19 vaccine developed by Pfizer and BioNTech is likely to protect against a more infectious variant of the virus, which was discovered in Britain and has spread around the world, according to results of further lab tests released on Wednesday.
